What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News FDA grants priority review for BioMarin’s PALYNZIQ to treat adolescents with phenylketonuria (PKU) Find out how BioMarin’s PALYNZIQ priority review could transform PKU treatment for adolescents and reshape the company’s rare-disease strategy. bySoujanya RaviOctober 29, 2025